Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-21

Clinical Trial Update: Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial update on the beta-blocker nebivolol for individuals with high normal blood pressure and/or a family history of hypertension; study completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

Sponsor: University of California, San Diego | Conditions: Pre-hypertension, Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2019-08-21